SCHEMBL28799660

SCHEMBL28799660

Cc1nn(C(=O)O)c(C)c1-c1cc(C(=O)c2nc3ccc(N4CCC(N(C)C)CC4)nc3[nH]2)ccn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 6/20 0.62
▸ CCND1 P24385 6/20 0.62
▸ CCND3 P30281 5/20 0.49
▸ CDK6 Q00534 5/20 0.49
▸ CDK1 P06493 3/20 0.49
▸ CCNB1 P14635 3/20 0.49
▸ CCNA2 P20248 3/20 0.48
▸ CDK2 P24941 3/20 0.48
▸ CCNA1 P78396 3/20 0.48
▸ WNT1 P04628 3/20 0.34
▸ GSK3B P49841 3/20 0.34
▸ DYRK1A Q13627 3/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ CLK2 P49760 1/20 0.34
▸ CLK3 P49761 1/20 0.34
▸ HRH3 Q9Y5N1 2/20 0.33
▸ HRH4 Q9H3N8 1/20 0.33
▸ KIT P10721 2/20 0.32
▸ FLT3 P36888 2/20 0.32
▸ ATR Q13535 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112177 0.91 CDK4 (0.75) CDK4CCND1CCND3CDK6CDK1
SCHEMBL2142195 0.90 CDK4 (0.58) CDK4CCND1CCND3CDK6CDK1
SCHEMBL111515 0.85 CDK4 (0.57) CDK4CCND1CCND3CDK6CDK1
SCHEMBL27880987 0.81 CDK4 (0.52) CDK4CCND1CCND3CDK6CDK1
SCHEMBL110439 0.80 CDK4 (0.51) CDK4CCND1CCND3CDK6CDK1
SCHEMBL113839 0.79 CDK4 (0.50) CDK4CCND1CCND3CDK6CDK1
SCHEMBL114897 0.78 CDK4 (0.44) CDK4CCND1KIT
SCHEMBL114117 0.77 CDK4 (0.78) CDK4CCND1CCND3CDK6CDK1
SCHEMBL110731 0.77 CDK4 (1.00) CDK4CCND1CCND3CDK6CDK1
SCHEMBL112120 0.76 CDK4 (0.55) CDK4CCND1CCND3CDK6CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102803225-A Imidazole derivatives and their use as modulators of cyclin dependent kinases NOVARTIS AG 2012-11-28 — — CN disclosed
Send feedback